Colorado Serum Company
Manufacturer and distributor of veterinary biologics and laboratory reagents. Produces vaccines, bacterins, toxoids, antitoxins and serum antibody products for livestock; conducts vaccine safety and efficacy evaluations; collaborates with regulatory and diagnostic laboratories on testing and product licensing; publishes veterinary guidance and product information for veterinary professionals and distributors.
Industries
Nr. of Employees
medium (51-250)
Colorado Serum Company
Denver, Colorado, United States, North America
Products
Tetanus antitoxin (including concentrated/purified formats)
Serum-derived antitoxin preparations intended to provide immediate passive immunity against tetanus toxin in susceptible animals.
Clostridium perfringens Types C & D antitoxin and toxoid-containing products
Antitoxins and toxoid vaccines targeting Clostridium perfringens types associated with enterotoxemia in livestock.
Normal equine serum and other equine-origin products
Equine-derived serum products for therapeutic or research use, subject to donor testing and regulatory controls.
West Nile virus antiserum
Serum-derived antibody preparations intended to provide passive protection or adjunctive therapy against West Nile virus.
Anthrax spore vaccine (veterinary)
Spore-based veterinary vaccine for anthrax prevention in livestock.
Brucella abortus vaccine, strain RB-51 (licensed vaccine)
Live Brucella abortus RB-51 vaccine for bovine immunization under veterinary supervision; product obtained full USDA licensing following safety and efficacy evaluations.
Tetanus antitoxin (including concentrated/purified formats)
Serum-derived antitoxin preparations intended to provide immediate passive immunity against tetanus toxin in susceptible animals.
Clostridium perfringens Types C & D antitoxin and toxoid-containing products
Antitoxins and toxoid vaccines targeting Clostridium perfringens types associated with enterotoxemia in livestock.
Normal equine serum and other equine-origin products
Equine-derived serum products for therapeutic or research use, subject to donor testing and regulatory controls.
West Nile virus antiserum
Serum-derived antibody preparations intended to provide passive protection or adjunctive therapy against West Nile virus.
Anthrax spore vaccine (veterinary)
Spore-based veterinary vaccine for anthrax prevention in livestock.
Brucella abortus vaccine, strain RB-51 (licensed vaccine)
Live Brucella abortus RB-51 vaccine for bovine immunization under veterinary supervision; product obtained full USDA licensing following safety and efficacy evaluations.
Services
Production and distribution of vaccines, bacterins, toxoids, antitoxins, antisera and related biological products for livestock and other veterinary uses.
Collaboration with diagnostic laboratories and regulatory agencies to develop or evaluate assays and to support donor herd testing programs.
Production and distribution of vaccines, bacterins, toxoids, antitoxins, antisera and related biological products for livestock and other veterinary uses.
Collaboration with diagnostic laboratories and regulatory agencies to develop or evaluate assays and to support donor herd testing programs.
Expertise Areas
- Veterinary vaccine development and manufacturing
- Serum antibody and antitoxin production
- Regulatory compliance for veterinary biologics
- Diagnostic testing for equine and livestock pathogens (qPCR and lab assays)
Key Technologies
- qPCR-based nucleic acid detection
- Formalin/formaldehyde inactivation
- Bacterin and toxoid vaccine production
- Modified-live vaccine attenuation techniques
News & Updates
USDA Center for Veterinary Biologics issued a full license for manufacture and distribution of Brucella abortus vaccine, strain RB-51 (live culture) following completion of required safety, efficacy and potency studies.
USDA Center for Veterinary Biologics issued a full license for manufacture and distribution of Brucella abortus vaccine, strain RB-51 (live culture) following completion of required safety, efficacy and potency studies.